A Randomized, Controlled Trial Evaluating Efficacy of Perioperative Organ Protection as Well as Safety of Ulinastatin Use in Pediatric Patients Undergoing Open Heart Surgery Through CPB to Treat Complex Congenital Heart Diseases

Trial Profile

A Randomized, Controlled Trial Evaluating Efficacy of Perioperative Organ Protection as Well as Safety of Ulinastatin Use in Pediatric Patients Undergoing Open Heart Surgery Through CPB to Treat Complex Congenital Heart Diseases

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Ulinastatin (Primary)
  • Indications Congenital heart defects
  • Focus Therapeutic Use
  • Sponsors Techpool Bio-Pharma
  • Most Recent Events

    • 13 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Mar 2018.
    • 13 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
    • 14 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top